Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living

University of Michigan Rogel Cancer Center

Status: Completed

Conditions: Ovarian Cancer

Treatments: Behavioral: Use of Purposeful app

Study type: Interventional

Funder types: Other

Identifiers

NCT04458168

HUM00140226 (Other Identifier)

UMCC 2018.153

Details and patient eligibility

About

In this pilot study, ovarian cancer survivors will be enrolled and followed for six months to evaluate usage of an eHealth app called "Purposeful".

Full description

This study will determine the feasibility and acceptability of Purposeful, the eHealth app. First, feasibility of enrolling ovarian cancer survivors to use Purposeful will be assessed. Secondly, the acceptability of the app among ovarian cancer survivors will be assessed, based on frequency of use and validated acceptability measures. Participants will be asked to complete other validated questionnaires so investigators may explore whether further research on the Purposeful app among ovarian cancer survivors is warranted. This will include correlations between use of the Purposeful app and the life purpose questionnaire score. Lastly, correlation between life purpose and quality of life in ovarian cancer survivors will be explored.

Enrollment: 120 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of ovarian cancer or treatment for ovarian cancer through the University of Michigan Gynecologic Oncology service
• Completed primary treatment (either surgery alone or surgery + chemotherapy)
• Ability to understand and the willingness to sign a written informed consent
• Ability to speak and read English

Exclusion criteria

• There are no additional exclusion criteria for participation in this study.

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

120 participants in 3 patient groups

Recently completed treatment

Experimental group

Description:

25 women who have just completed treatment

Treatment:

Behavioral: Use of Purposeful app

No recurrence of ovarian cancer for at least one year

Experimental group

Description:

25 women who have not experienced a recurrence of their ovarian cancer at least one year after their initial diagnosis

Treatment:

Behavioral: Use of Purposeful app

Recurrence of ovarian cancer

Experimental group

Description:

25 women who have experienced a recurrence of their ovarian cancer after primary treatment

Treatment:

Behavioral: Use of Purposeful app